The complaint filed by Wise goes on to state,
“Due to the defective nature of Xarelto, persons who were prescribed and ingested Xarelto, for even a brief period of time, including the Ingesting Decedent herein, were at increased risk for developing life-threatening bleeds. Due to the flawed formulation of Xarelto, which according to defendants does not require regular blood monitoring or frequent doctor follow-up, raises concerns about the risk of stroke, bleeding, and blood clots if not taken properly or absorbed properly, particularly in patients with poor renal function.”
Even more significantly, the complaint alleges that The Institute for Safe Medication Practices identified 356 reports of serious, disabling, or fatal injury in which rivaroxaban (Xarelto) was the primary suspect drug.
Wise is seeking punitive damages from the makers of Xarelto for fraud, wrongful death,consumer law violations, negligence, failure to warn, product liability, unreasonable marketing of a dangerous drug, and breach of warranty.
Philadelphia personal injury lawyers at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury lawyers and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you or a loved one has suffered a serious reaction to Xarelto, a defective pharmaceutical drug product, or any other type of personal injury, you may wish to confer with a lawyer who can help you obtain compensation for medical expenses, pain and suffering, and more. Contact the personal injury lawyers of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw or submit a free online inquiry to learn more about your legal rights and options to file a Xarelto lawsuit.